Key Financial’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Other funds holding NBIX
Key Financial's NBIX Position: Q3 2026 in Review
Key Financial held its Neurocrine Biosciences (NBIX) position steady in Q3 2026 at 34 shares worth $4.82K. The position accounts for ﹤0.01% of the portfolio, ranked #1001.
Key Financial first reported a position in NBIX in Q2 2023 and has held it in 14 quarters since. The position peaked at $5.73K in Q2 2026. 630 funds tracked by Wall St. Rank hold NBIX as of Q3 2026.
- Key Financial held 34 shares of Neurocrine Biosciences worth $4.82K as of Q3 2026.
- Key Financial left its Neurocrine Biosciences share count unchanged in Q3 2026.
- Neurocrine Biosciences made up ﹤0.01% of Key Financial's portfolio in Q3 2026, its #1001 holding.
- Key Financial first reported a position in Neurocrine Biosciences in Q2 2023 and has held it in 14 quarters since.
- Key Financial's Neurocrine Biosciences position peaked at $5.73K in Q2 2026.
- 630 funds tracked by Wall St. Rank held Neurocrine Biosciences as of Q3 2026.
Based on Key Financial's 13F filing for Q3 2026, filed 2 Nov 2026.